Bioinformatics and In Vitro Studies Reveal the Importance of p53, PPARG and Notch Signaling Pathway in Inhibition of Breast Cancer Stem Cells by Hesperetin

Adam Hermawan ^1,2 * , Muthi Ikawati ^1,2, Annisa Khumaira ², Herwandhani Putri ², Riris Istighfari Jenie ^1,2, Sonia Meta Angraini ², Haruma Anggraini Muflikhasari ²

Cited by CrossRef: 3

1- Wu J, Luo M, Chen Z, Li L, Huang X. Integrated Analysis of the Expression Characteristics, Prognostic Value, and Immune Characteristics of PPARG in Breast Cancer. Front Genet. 2021;12 [Crossref]

2- Ou M, Deng Z, Shi Y, He J, Ye Z, Guo M, Cheng G, Wu J, Lv L. Mechanism of Apigenin against breast cancer stem cells: network pharmacology and experimental validation. Front Pharmacol. 2024;15 [Crossref]

3- Hermawan A, Ikawati M, Putri D, Fatimah N, Prasetio H. Nobiletin Inhibits Breast Cancer Stem Cell by Regulating the Cell Cycle: A Comprehensive Bioinformatics Analysis and In Vitro Experiments . Nutrition and Cancer. 2024;76(7):638 [Crossref]

4- Bakhshan M, Sheikhzadeh S, Delirezh N. Hesperidin nanoparticles for prostate cancer therapy: preparation, characterization and cytotoxic activity. Biomed Mater. 2024;19(3):035044 [Crossref]